Cspc Pharmaceutical | 1093 - 流动资产



金融业
股票价格
CNY
资产
CNY 46.7B
现金及等价物
CNY 6.09B
销售成本
CNY 2.11B
流动资产
CNY 22.25B
流动负债
CNY 10.18B
债务
CNY 641.11M
股息收益率
CNY 2.92
EBIT
CNY 206.26M
EBITDA
CNY 2.19B
员工
CNY 23.5K
EPS每股收益
CNY 0.08
股本和储备
CNY 33.18B
销售毛利
CNY 4.01B
债务利息支出
CNY 6.76M
贷款资金
CNY 180.69M
市值
CNY 101.14B
净收入
CNY 370.72M
营业费用
CNY 5.91B
营业利润
CNY 206.26M
普通股股本
CNY 11.52B
PE价格收益
23.62
税前利润
CNY 505.59M
销售收入
CNY 6.47B
销售和管理费用
CNY 1.87B
股票
CNY 3.09B
贸易债权人
CNY 2.32B
应收帐款人
CNY 8.79B


流动资产 更改 日
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Jiangsu Hengrui CNY 52.04B 553.82M 2026-03
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Moderna USD 5.82B 45M 2026-06
Organon & Co USD 4.93B 580M 2026-03
Revvity USD 2.3B 169.4M 2026-06
Sh Fosun Pharma CNY 33.96B 144.01M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Viatris USD 10.06B 861.1M 2026-06
Wuxi Apptec CNY 73.15B 7.98B 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03